Home  >  News
Marketing
+ Font Resize -

Zydus gets US FDA marketing nod for desvenlafaxine ER tablets

Our Bureau, Mumbai
Thursday, October 12, 2017, 12:50 Hrs  [IST]

Zydus Cadila has received the final approval from the US FDA to market desvenlafaxine extended-release tablets, 50 mg 100mg. The drug is used to treat major depression and will be manufactured at the Group's formulations manufacturing facility at Moraiya, Ahmedabad.

The group now has more than 160 approvals and has so far filed over 300 ANDAs since the commencement of the filing process in FY 2003-04.

 

*POST YOUR COMMENT
Comments
* Name :     
* Email :    
  Website :  
   
     
 
IPJPI_150x60en_2017
acssymposium
CPhI-WWW-150x60-stat-v1
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |